These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33853992)

  • 1. Academic Research Consortium for High Bleeding Risk Definitions for Early, Late, and Very Late Bleeding Events.
    Miura K; Shima Y; Okabe K; Taguchi Y; Ikuta A; Takahashi K; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2021 May; 85(6):797-805. PubMed ID: 33853992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified Definition.
    Miura K; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Tada T; Tanaka H; Fuku Y; Goto T; Kadota K
    Circ J; 2020 Aug; 84(9):1560-1567. PubMed ID: 32669530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
    Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
    Takahashi K; Miura K; Shima Y; Okabe K; Ikuta A; Taguchi Y; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    J Cardiol; 2022 Aug; 80(2):155-161. PubMed ID: 35282943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.
    Wang HY; Dou KF; Yin D; Zhang D; Gao RL; Yang YJ
    BMC Cardiovasc Disord; 2020 Jul; 20(1):313. PubMed ID: 32611318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
    Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk.
    Shima Y; Miura K; Shimada T; Ohya M; Murai R; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Int J Cardiol; 2021 Mar; 326():12-18. PubMed ID: 33152414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic and Bleeding Events in PENDULUM Patients With High Bleeding Risk and High Platelet Reactivity.
    Iijima R; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Akasaka T; Shinke T; Ueno T; Hirayama A; Uemura S; Harada A; Kuroda T; Takita A; Murakami Y; Saito S; Nakamura M
    Circ J; 2022 Apr; 86(5):763-771. PubMed ID: 34880154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
    Zocca P; Kok MM; van der Heijden LC; Danse PW; Schotborgh CE; Scholte M; Hartmann M; Linssen GCM; Doggen CJM; von Birgelen C
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):567-576. PubMed ID: 30143879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
    Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
    J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
    Zocca P; Kok MM; van der Heijden LC; van Houwelingen KG; Hartmann M; de Man FHAF; Stoel MG; Louwerenburg JHW; Knottnerus IL; Linssen GCM; Doggen CJM; von Birgelen C
    Int J Cardiol; 2018 Oct; 268():11-17. PubMed ID: 29801763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G
    Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
    Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
    Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
    J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions.
    Tomoi Y; Kuramitsu S; Shinozaki T; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
    EuroIntervention; 2023 Apr; 18(16):e1368-e1377. PubMed ID: 36579610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
    Wang HY; Wang Y; Yin D; Gao RL; Yang YJ; Xu B; Dou KF
    J Interv Cardiol; 2020; 2020():2985435. PubMed ID: 32405273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
    Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.
    Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    Cardiovasc Interv Ther; 2021 Jan; 36(1):91-103. PubMed ID: 32086787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.